ISOTHIAZOLOPYRIMIDINONES, PYRAZOLOPYRIMIDINONES, AND PYRROLOPYRIMIDINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS
申请人:Forma Therapeutics, Inc.
公开号:US20160229872A1
公开(公告)日:2016-08-11
The disclosure relates to inhibitors of USP7 inhibitors useful in the treatment of cancers, neurodegenerative diseases, immunological disorders, inflammatory disorders, cardiovascular diseases, ischemic diseases, viral infections and diseases, and bacterial infections and diseases, having the Formula:
where R
1
, R
2
, R
3
, R
4
, R
5
, R
5′
, X
1
, X
2
, X
3
, n, and m are described herein.
该披露涉及对USP7抑制剂的抑制剂,用于治疗癌症、神经退行性疾病、免疫性疾病、炎症性疾病、心血管疾病、缺血性疾病、病毒感染和疾病以及细菌感染和疾病,其化学式为:其中R1、R2、R3、R4、R5、R5'、X1、X2、X3、n和m如所述。